Daniele Veritti

20PUBLICATIONS
60CO-AUTHORS
Optical technologyAutoimmunityChemical and thermal processes in energy and combustionNanomedicineMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 06, 2026
Switching to aflibercept 8 mg in neovascular age-related macular degeneration: real-world outcomes according to switch indication.

|Jun 25, 2026
Iridology: Biological plausibility, clinical evidence, and implications for ophthalmic practice : A position paper of the Associazione Pazienti Malattie Oculari (APMO).

|Feb 26, 2026
Reducing the Carbon Footprint of Neovascular Age-Related Macular Degeneration Therapy: Environmental Impact of Transitioning to Aflibercept 8 mg.

Daniele Veritti, Micaela Misciagna, Cristian Teatino

|Feb 25, 2026
AI-assisted analysis of early fluid dynamics following aflibercept 8 mg in treatment-naïve neovascular AMD.

Daniele Veritti, Valentina Sarao, Asia Amelia Martin

|Nov 27, 2025
AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study.

Edoardo Midena, Marco Lupidi, Lisa Toto

|Apr 01, 2025
Early intraocular pressure dynamics following aflibercept 8 mg versus aflibercept 2 mg: a propensity score-matched analysis.

Valentina Sarao, Daniele Veritti, Francesco Bonini

Pageof 4

Frequent Collaborators

17 joint publications

Paolo Lanzetta

12 joint publications

Valentina Sarao

2 joint publications

Marco Lombardo

2 joint publications

Enrico Borrelli